Brighton Jones LLC’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $475K | Buy |
6,802
+1,031
| +18% | +$72K | 0.01% | 557 |
|
|
2025
Q1 | $424K | Sell |
5,771
-11
| -0.2% | -$809 | 0.01% | 439 |
|
|
2024
Q4 | $379K | Buy |
5,782
+2,789
| +93% | +$183K | 0.01% | 461 |
|
|
2024
Q3 | $233K | Sell |
2,993
-1,409
| -32% | -$110K | 0.01% | 495 |
|
|
2024
Q2 | $343K | Sell |
4,402
-127
| -3% | -$9.9K | 0.01% | 443 |
|
|
2024
Q1 | $307K | Buy |
4,529
+59
| +1% | +$4K | 0.01% | 459 |
|
|
2023
Q4 | $301K | Buy |
4,470
+1,002
| +29% | +$67.5K | 0.01% | 444 |
|
|
2023
Q3 | $235K | Buy |
3,468
+150
| +5% | +$10.2K | 0.01% | 463 |
|
|
2023
Q2 | $237K | Buy |
+3,318
| New | +$237K | 0.01% | 460 |
|